(131)I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma

AIM: To investigate the safety and effectiveness of combined (131)I-metuximab and transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). METHODS: One hundred and eighty-five patients (159 men and 26 women) with advanced HCC were enrolled in this study from February 2009...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: He, Qing, Lu, Wu-Sheng, Liu, Yang, Guan, Yong-Song, Kuang, An-Ren
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Co., Limited 2013
Gaiak:
Brief Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870565/
https://ncbi.nlm.nih.gov/pubmed/24379637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i47.9104
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak